44. Management of HCV Infection and Liver Transplantation

  1. John WD McDonald Professor of Medicine2,
  2. Andrew K Burroughs Professor of Hepatology Consultant Physician/Hepatologist3,
  3. Brian G Feagan Professor of Medicine2 and
  4. M Brian Fennerty Professor of Medicine4
  1. Brett E Fortune,
  2. Hugo R Rosen and
  3. James R Burton Jr

Published Online: 22 JUL 2010

DOI: 10.1002/9781444314403.ch44

Evidence-Based Gastroenterology and Hepatology, Third Edition

Evidence-Based Gastroenterology and Hepatology, Third Edition

How to Cite

Fortune, B. E., Rosen, H. R. and Burton, J. R. (2010) Management of HCV Infection and Liver Transplantation, in Evidence-Based Gastroenterology and Hepatology, Third Edition (eds J. W. McDonald, A. K. Burroughs, B. G. Feagan and M. B. Fennerty), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444314403.ch44

Editor Information

  1. 2

    Robarts Clinical Trials, Robarts Research Unit, University of Western Ontario, London, Ontario, Canada

  2. 3

    The Royal Free Sheila Sherlock Liver Centre, Royal Free Hospital, and University College London, London, UK

  3. 4

    Oregon Health and Science University, Division of Gastroenterology and Hepatology, Portland, Oregon, USA

Author Information

  1. University of Colorado, Denver, Colorado, USA

Publication History

  1. Published Online: 22 JUL 2010
  2. Published Print: 10 SEP 2010

ISBN Information

Print ISBN: 9781405181938

Online ISBN: 9781444314403

SEARCH

Keywords:

  • Natural history of recurrent HCV;
  • Factors associated with severe HCV recurrence;
  • Treatment of recurrent HCV;
  • Pre-transplant antiviral therapy;
  • hepatic venous pressure gradients (HVPG);
  • Treatment of established disease;
  • Risk of acute cellular rejection and alloimmune hepatitis;
  • low accelerating dose regimen (LADR);
  • Management of HCV infection and liver transplantation;
  • Hepatitis C virus (HCV)

Summary

This chapter contains sections titled:

  • Introduction

  • Natural history of recurrent HCV

  • Factors associated with severe HCV recurrence

  • Treatment of recurrent HCV

  • Pre-transplant antiviral therapy

  • Preemptive antiviral treatment

  • Treatment of established disease

  • Risk of acute cellular rejection and alloimmune hepatitis

  • Retransplantation for allograft cirrhosis

  • Summary

  • References